LGVN: Longeveron Inc. Stock

by  •  • Comments Off on LGVN: Longeveron Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 18.06
Enterprise Value ($M) 3.73
Book Value ($M) 17.16
Book Value / Share 1.27
Price / Book 1.05
NCAV ($M) 11.59
NCAV / Share 0.86
Price / NCAV 1.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.92
Return on Assets (ROA) -1.75
Return on Equity (ROE) -5.57

Liquidity (mrq)
Quick Ratio 5.61
Current Ratio 5.61

Balance Sheet (mrq) ($M)
Current Assets 15.28
Assets 20.85
Liabilities 3.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.39
Operating Income -16.52
Net Income -15.97

Cash Flow Statement (mra) ($M)
Cash From Operations -13.87
Cash from Investing -0.64
Cash from Financing 28.79

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -63.17
2024-04-17 13G Intracoastal Capital, Llc 4.99
2024-04-15 13D/A Hare Joshua 25.70 -86.42

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 67,618 450,216 15.02
2025-05-08 43,000 105,881 40.61
2025-05-07 29,851 82,606 36.14
2025-05-06 28,130 100,515 27.99
2025-05-05 16,320 48,902 33.37

(click for more detail)

Similar Companies
KZR – Kezar Life Sciences, Inc. LEXX – Lexaria Bioscience Corp.
LFVN – LifeVantage Corporation LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc.


Financial data and stock pages provided by
Fintel.io